Genetics consortiums can offer views facilitating best practice in Alzheimer’s disease

od Lovestone, Simon
Izdano 1998

Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease

od Lovestone, Simon
Izdano 2000

Blood biomarkers for Alzheimer’s disease

od Lovestone, Simon
izdano v Genome Med (2014)

The European medical information framework: A novel ecosystem for sharing healthcare data across Europe

od Lovestone, Simon
izdano v Learn Health Syst (2019)

Blood-based biomarkers of Alzheimer’s disease: challenging but feasible

od Thambisetty, Madhav, Lovestone, Simon
Izdano 2010

Management of dementia /

od Lovestone, Simon, Gauthier, Serge
Izdano c200

Advanced glycation end products, dementia, and diabetes

od Lovestone, Simon, Smith, Ulf
Izdano 2014

The GSK3 hypothesis of Alzheimer's disease

od Hooper, Claudie, Killick, Richard, Lovestone, Simon
Izdano 2008

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach

od Nevado-Holgado, Alejo J, Lovestone, Simon
izdano v Comput Struct Biotechnol J (2016)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers

od Hooper, Claudie, Lovestone, Simon, Sainz-Fuertes, Ricardo
Izdano 2008

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology

od Baird, Alison L., Westwood, Sarah, Lovestone, Simon
izdano v Front Neurol (2015)

The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons

od Hooper, Claudie, Chapple, J. Paul, Lovestone, Simon, Killick, Richard
Izdano 2007

The Importance of Tau Phosphorylation for Neurodegenerative Diseases

od Noble, Wendy, Hanger, Diane P., Miller, Christopher C. J., Lovestone, Simon
Izdano 2013

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease

od Winchester, Laura M., Powell, John, Lovestone, Simon, Nevado-Holgado, Alejo J.
izdano v Genome Med (2018)

Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery

od Cepeda, M. Soledad, Kern, David M., Seabrook, Guy R., Lovestone, Simon
izdano v Clin Drug Investig (2019)

Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications

od Kern, David M., Cepeda, M. Soledad, Lovestone, Simon, Seabrook, Guy R.
izdano v Alzheimers Dement (N Y) (2019)

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells

od Hooper, Claudie, Meimaridou, Eirini, Tavassoli, Mahvash, Melino, Gerry, Lovestone, Simon, Killick, Richard
Izdano 2007

Ageing Increases Vulnerability to Aβ42 Toxicity in Drosophila

od Rogers, Iain, Kerr, Fiona, Martinez, Pedro, Hardy, John, Lovestone, Simon, Partridge, Linda
Izdano 2012

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank

od Nevado-Holgado, Alejo J, Kim, Chi-Hun, Winchester, Laura, Gallacher, John, Lovestone, Simon
izdano v BMJ Open (2016)

Effects of freezer storage time on levels of complement biomarkers

od Morgan, Angharad R., O’Hagan, Caroline, Touchard, Samuel, Lovestone, Simon, Paul Morgan, B.
izdano v BMC Res Notes (2017)